Literature DB >> 19821101

The expression of resistin in adipose tissues of patients with polycystic ovary syndrome and insulin resistance.

Yongli Chu1, Qing Cui, Guijiao Feng, Zhiyun Song, Xueqiang Jiang.   

Abstract

The relationship between the expression of resistin in polycystic ovary syndrome (PCOS) and insulin resistance was investigated. The plasma resistin concentrations in 35 patients with PCOS and 40 controls were measured by ELISA. Luteinizing hormone (LH), follicle-stimulating hormone (FSH), and fasting insulin (FIN) were tested by radioimmunoassay. Insulin resistance index (HOMA-IR) was calculated. Fasting plasma glucose (FPG) was determined by oxidase test. Western blot and reverse transcriptase PCR (RT-PCR) methods were used to detect the expression of resistin in adipose tissues. The levels of plasma resistin, LH, LH/FSH and FIN and HOMA-IR in patients with PCOS were significantly higher than those in control group (all P<0.05). Plasma resistin was correlated positively with FPG, FIN, HOMA-IR, LH and LH/FSH (r=0.56, 0.60, 0.65, 0.48, and 0.42 respectively). Resistin protein and mRNA expression levels in patients with PCOS were significantly higher than those in normal tissues (all P<0.01). It was concluded that resistin might be involved in the pathogenesis of insulin resistance of PCOS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19821101     DOI: 10.1007/s11596-009-0521-6

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  24 in total

1.  Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production.

Authors:  Michael W Rajala; Silvana Obici; Philipp E Scherer; Luciano Rossetti
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

2.  Resistin, central obesity, and type 2 diabetes.

Authors:  C L McTernan; P G McTernan; A L Harte; P L Levick; A H Barnett; S Kumar
Journal:  Lancet       Date:  2002-01-05       Impact factor: 79.321

Review 3.  Resistin and obesity-associated insulin resistance.

Authors:  Claire M Steppan; Mitchell A Lazar
Journal:  Trends Endocrinol Metab       Date:  2002 Jan-Feb       Impact factor: 12.015

4.  Increased resistin expression in the adipose tissue of male prolactin transgenic mice and in male mice with elevated androgen levels.

Authors:  C Ling; J Kindblom; H Wennbo; H Billig
Journal:  FEBS Lett       Date:  2001-10-26       Impact factor: 4.124

5.  Circulating resistin levels are not associated with fat redistribution, insulin resistance, or metabolic profile in patients with the highly active antiretroviral therapy-induced metabolic syndrome.

Authors:  Diana Barb; Sanjivini G Wadhwa; Juergen Kratzsch; Alina Gavrila; Jean L Chan; Catherine J Williams; Adolf W Karchmer; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2005-06-14       Impact factor: 5.958

6.  Metformin does not enhance ovulation induction in clomiphene resistant polycystic ovary syndrome in clinical practice.

Authors:  N D C Sturrock; B Lannon; T N Fay
Journal:  Br J Clin Pharmacol       Date:  2002-05       Impact factor: 4.335

7.  Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans.

Authors:  D B Savage; C P Sewter; E S Klenk; D G Segal; A Vidal-Puig; R V Considine; S O'Rahilly
Journal:  Diabetes       Date:  2001-10       Impact factor: 9.461

8.  Human resistin gene, obesity, and type 2 diabetes: mutation analysis and population study.

Authors:  Federica Sentinelli; Stefano Romeo; Marcello Arca; Emanuela Filippi; Frida Leonetti; Michela Banchieri; Umberto Di Mario; Marco Giorgio Baroni
Journal:  Diabetes       Date:  2002-03       Impact factor: 9.461

9.  Insulin resistance in nonobese patients with polycystic ovarian disease.

Authors:  R J Chang; R M Nakamura; H L Judd; S A Kaplan
Journal:  J Clin Endocrinol Metab       Date:  1983-08       Impact factor: 5.958

10.  Acanthosis Nigricans, insulin action, and hyperandrogenism: clinical, histological, and biochemical findings.

Authors:  A Dunaif; G Green; R G Phelps; M Lebwohl; W Futterweit; L Lewy
Journal:  J Clin Endocrinol Metab       Date:  1991-09       Impact factor: 5.958

View more
  4 in total

1.  Assessing and treating insulin resistance in women with polycystic ovarian syndrome.

Authors:  Michael L Traub
Journal:  World J Diabetes       Date:  2011-03-15

2.  Impact of luteinized unruptured follicles on endometrial receptivity.

Authors:  Wangming Xu; Jing Yang; Lei Jiang; Jing Hu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-04-20

3.  Novel oncogenic and chemoresistance-inducing functions of resistin in ovarian cancer cells require miRNAs-mediated induction of epithelial-to-mesenchymal transition.

Authors:  Ling Qiu; Guo-Feng Zhang; Lei Yu; Hong-Yong Wang; Xiao-Jing Jia; Tie-Jun Wang
Journal:  Sci Rep       Date:  2018-08-21       Impact factor: 4.379

4.  Circulating resistin and follistatin levels in obese and non-obese women with polycystic ovary syndrome: A systematic review and meta-analysis.

Authors:  Tahereh Raeisi; Hossein Rezaie; Mina Darand; Akram Taheri; Nazila Garousi; Bahman Razi; Leonardo Roever; Reza Mohseni; Shimels Hussien Mohammed; Shahab Alizadeh
Journal:  PLoS One       Date:  2021-03-19       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.